The company reported revenue of $3.52 billion, up from $3.33 billion in Q4 2024 but below the Wall Street consensus estimate of $3.56 billion.
NEW YORK – Lex Diagnostics said on Monday that it has obtained 510 (k) clearance and CLIA waiver from the US Food and Drug Administration for its Velo point-of-care molecular diagnostic system and an ...
Net proceeds from the private placement will be used to fund ongoing operations, address outstanding liabilities, and preserve the company's ability to operate.
NEW YORK — Bio-Techne said on Monday that its Ella benchtop immunoassay platform has received CE-IVD marking, permitting its sale in the EU.
The agreement pertains to multiple immunoassay analyzers and test menus that QuidelOrtho expects will increase its competitiveness in international tenders.
The automated image assessment software uses artificial intelligence to sort images of bacterial culture plates.
Last week, readers were most interested in a story about the use of blood-based tests for asymptomatic Alzheimer's patients.
The company plans to begin using the instrument in its Burlington, North Carolina, lab in the first quarter of the year and ...
The transition from testing the dead to testing the living is the latest example of how genomics is expanding horizons for ...
The researchers measured the variation in DNA methylation patterns to develop the method and applied it to multiple types of cancer.
The firm saw a 26 percent increase in screening revenue and a 14 percent increase in precision oncology revenue during the quarter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results